The global blood collection devices market is poised for substantial growth, projected to increase from USD 9.13 billion in 2025 to USD 13.02 billion by 2030, registering a CAGR of 7.4% during the forecast period. As healthcare systems worldwide continue to prioritize accurate diagnostics, patient safety, and efficient blood management, blood collection devices are becoming increasingly essential across hospitals, diagnostic laboratories, blood banks, and research institutions.
Blood collection serves as the foundation of modern diagnostics and transfusion medicine. Whether for routine health screenings, chronic disease monitoring, infectious disease detection, or blood donation programs, the demand for reliable blood collection technologies continues to rise. With growing healthcare needs and technological advancements, the industry is witnessing a new wave of innovation aimed at improving collection efficiency, sample quality, and patient comfort.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39733117
Why the Blood Collection Devices Market Is Experiencing Strong Growth
One of the primary drivers of market expansion is the increasing prevalence of chronic, infectious, and lifestyle-related diseases worldwide. Conditions such as diabetes, cardiovascular diseases, cancer, kidney disorders, and infectious diseases require frequent blood testing for diagnosis, treatment monitoring, and disease management.
The growing global healthcare infrastructure is also contributing significantly to market growth. Rising numbers of hospitals, diagnostic centers, ambulatory care facilities, and blood banks are creating sustained demand for blood collection tubes, needles, lancets, syringes, blood bags, and apheresis systems.
In addition, increasing awareness regarding voluntary blood donation programs is supporting market development. Governments, healthcare organizations, and non-profit institutions are investing heavily in blood donation campaigns to ensure adequate blood supply for emergency care, surgeries, trauma treatment, and chronic disease management.
Another important trend is the growing adoption of minimally invasive blood collection technologies. Healthcare providers are increasingly seeking solutions that reduce patient discomfort while maintaining sample accuracy and laboratory-quality results.
Innovation and Strategic Partnerships Are Driving Industry Transformation
The competitive landscape is evolving rapidly as leading manufacturers invest in product innovation, digital integration, automation, and strategic collaborations.
In January 2025, Terumo BCT signed a Memorandum of Understanding (MoU) with the Shandong Institute of Medical Devices and Pharmaceutical Packaging Inspection to strengthen research and innovation in blood component collection technologies. The partnership reflects the industry’s growing focus on advancing collection efficiency and safety standards.
Another notable development occurred in December 2024, when Becton, Dickinson and Company (BD) partnered with Babson Diagnostics to launch the BD MiniDraw Capillary Blood Collection System. The innovative system enables laboratory-quality testing using as few as six drops of blood collected from a patient’s finger, potentially transforming blood testing accessibility and convenience.
Across the industry, companies are increasingly investing in automation, smart blood management systems, and advanced collection technologies designed to improve workflow efficiency, reduce contamination risks, and enhance patient experiences.
Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=39733117
Companies Leading the Blood Collection Devices Market
Several global healthcare and medical technology companies continue to shape the future of blood collection through innovation, manufacturing excellence, and strategic expansion.
Fresenius Kabi AG
Fresenius Kabi is currently the largest player in the blood collection devices market. The company maintains a strong position through its extensive portfolio of blood bags and transfusion-related products.
Its success is supported by strong customer trust, global distribution capabilities, and a long-standing reputation for quality. Fresenius has increasingly focused on automation initiatives and sustainable manufacturing practices while expanding aggressively across Asia Pacific and Latin America, where healthcare investments and blood donation programs continue to grow.
The company’s advanced blood collection and transfusion solutions have helped establish it as a preferred partner for hospitals, blood banks, and healthcare institutions worldwide.
Becton, Dickinson and Company
BD remains one of the most influential companies in the blood collection devices industry. Its widely recognized Vacutainer product line has become a standard in hospitals and laboratories around the world.
The company offers one of the industry’s most comprehensive portfolios, including blood collection tubes, syringes, needles, lancets, and blood bag systems. Recent innovations such as the BD MiniDraw platform demonstrate the company’s commitment to less-invasive blood collection technologies and improved patient experiences.
BD continues to strengthen its market position through innovation in capillary blood collection, point-of-care diagnostics, and digital health integration.
Terumo BCT, Inc.
Terumo BCT is recognized globally for its expertise in blood component collection and apheresis technologies. The company has built a strong reputation through advanced collection systems that enhance both donor safety and operational efficiency.
In 2024, the launch of the Intercept 10 Platelet System further strengthened its position in platelet collection and blood component management. Terumo is also investing heavily in digital blood management platforms, manufacturing expansion, and emerging technologies that support both blood collection and cell-based therapies.
Its focus on innovation and global expansion continues to make it one of the industry’s most dynamic players.
Greiner Bio-One
Greiner Bio-One has established a strong presence through its VACUETTE blood collection portfolio. The company’s products are widely trusted for maintaining sample integrity and ensuring compatibility with modern laboratory automation systems.
Its emphasis on quality, precision, and diagnostic efficiency has helped strengthen its position in hospitals and clinical laboratories globally.
Cardinal Health
Cardinal Health plays a significant role in the market through its broad portfolio of medical and laboratory supplies. The company’s extensive distribution network and customer-focused approach enable it to serve healthcare providers efficiently across multiple regions.
Its strong logistics infrastructure continues to support growth in both mature and emerging healthcare markets.
Market Competition Remains Highly Dynamic
The blood collection devices market remains intensely competitive, with the top five companies accounting for a substantial portion of global revenues. Industry leaders continue to compete through product innovation, manufacturing capabilities, geographic expansion, and strategic partnerships.
Fresenius Kabi, BD, Terumo BCT, Greiner Bio-One, and Cardinal Health maintain leadership positions due to their comprehensive product portfolios and strong global distribution networks.
At the same time, numerous regional and emerging manufacturers are expanding their presence by offering specialized products and cost-effective alternatives. This competitive environment encourages continuous innovation and creates opportunities for new entrants to gain market share.
What’s Next for the Blood Collection Devices Market?
The future of the blood collection devices market appears highly promising as healthcare systems increasingly emphasize preventive care, early disease detection, and efficient diagnostic workflows.
Technological advancements are expected to drive the next phase of market growth. Automated blood collection systems, smart sample tracking technologies, digital blood management platforms, and minimally invasive collection devices are likely to become more prevalent across healthcare settings.
Additionally, the growing demand for point-of-care testing and home-based diagnostics may accelerate the adoption of capillary blood collection technologies that require smaller sample volumes while maintaining laboratory-quality accuracy.
As healthcare providers seek safer, faster, and more patient-friendly solutions, manufacturers will continue investing in innovation to meet evolving clinical needs.
Ultimately, blood collection devices have become far more than simple diagnostic tools. They represent a critical link in the healthcare ecosystem, enabling accurate diagnosis, effective treatment planning, and life-saving transfusion therapies. Supported by rising healthcare investments, expanding diagnostic testing, and ongoing technological innovation, the market is well-positioned for sustained growth through 2030 and beyond.
Enquire Before Buying @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=39733117